These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease. Matsumoto S, Mashima H. Sci Rep; 2020 Dec 17; 10(1):22176. PubMed ID: 33335169 [Abstract] [Full Text] [Related]
11. Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies. Sandborn WJ, Hanauer S, Lichtenstein GR, Safdi M, Edeline M, Scott Harris M. Aliment Pharmacol Ther; 2011 Oct 17; 34(7):747-56. PubMed ID: 21848857 [Abstract] [Full Text] [Related]
17. Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis. Michelini Z, Baroncelli S, Fantauzzi A, Pasquale C, Galluzzo CM, Sanchez M, Gatto M, Amici R, Franco M, d'Ettorre G, Fimiani C, Mezzaroma I, Vullo V, Merli M, Palmisano L. HIV Clin Trials; 2016 Mar 17; 17(2):49-54. PubMed ID: 26739837 [Abstract] [Full Text] [Related]